The Substance Abuse and Mental Heal...

The Substance Abuse and Mental Health Services Administration (SAMHSA) is conducting a series of sessions to train physicians onward the proper administration of buprenorphine (Subutex) and appropriate follow-up care.

Buprenorphine and the combination buprenorphine and naloxone (Suboxone) were freshly approved by the U.S. nourishment and Drug Administration for treatment of opioid addictions, so as prescription painkillers and heroin. Unlike other medications available to treat patients with addictions, buprenorphine can be administered by means of physicians in an office-based setting for the detoxification and maintenance of addiction.

To prescribe buprenorphine, physicians must obtain a waiver from provisions of the federal Controll Substances Act and ended eight hours of training mandated through the U.S. Congress.

The eight-hour training sessions will be held in a number of cities in the spring and summer A unimpaired listing is available on the SAMHSA's Web site at www.buprenorphine.samhsa.gov or by way of calling 866-BUP-CSAT (287-2728).

COPYRIGHT 2003 American Academy of Family Physicians

COPYRIGHT 2003 Gale Group